New CAN-SPAM review increases risk for practices that email their patients
Practices that use email to market services and products to patients should expect more scrutiny. The Federal Trade Commission (FTC) is examining its CAN-SPAM rules that prohibit certain unsolicited email messaging, and the stakes are high for practices.
To read the full article, sign in and subscribe to the DecisionHealth Newsletters.